COLORADO – July 2025 – Rocky Mountain Cancer Centers (RMCC) is proud to share that 15 of its distinguished physician oncologists in the Denver and North Denver region have been named to 5280 Magazine’s esteemed “Top Docs” list for 2025. This honor is especially meaningful as it reflects nominations and selections made by fellow physicians in the Denver area, underscoring the high level of trust and respect these doctors have earned within the medical community.
The entire RMCC team proudly congratulates our esteemed colleagues:
We are incredibly proud of this recognition of our physicians’ excellence in the Denver and North Denver regions. These nominations showcase the outstanding dedication and specialized expertise of RMCC’s doctors, who are committed exclusively to cancer care. Their focused experience and deep knowledge span a broad spectrum of cancer types and treatment options, ensuring patients receive the highest level of care.
“We are deeply proud to see our physicians honored by their peers in the Denver and North Denver medical community,” said Manojkumar Bupathi, MD, MS, president and medical oncologist at RMCC. “Being recognized by fellow physicians is one of the greatest forms of respect and reflects the dedication, expertise, and compassionate care our oncologists deliver every day. It’s a true testament to their ongoing commitment to advancing cancer care and achieving the best possible outcomes for our patients.”
With multiple locations throughout the Denver metro area and North Denver, RMCC is uniquely positioned to deliver world-class cancer care — including advanced therapies and clinical trials — conveniently within patients’ own communities. RMCC’s physician oncologists are committed to developing personalized treatment plans tailored to each patient, drawing on the latest evidence-based practices and cutting-edge research.
“These ‘Top Doc’ nominations provide our patients with important reassurance that they are being cared for by some of the region’s most respected and skilled cancer specialists,” said Alonso Pacheco, MD, medical director, medical oncologist, and hematologist at Rocky Mountain Cancer Centers. “At RMCC, our top physicians go beyond medical treatment by offering comprehensive support services, ensuring that patients and their families receive compassionate care and guidance throughout every stage of their cancer journey. This holistic approach, paired with advanced treatments and access to clinical trials, is what truly distinguishes RMCC.”
Being named to 5280 Magazine’s “Top Docs” list highlights RMCC’s dedication to excellence in oncology and reinforces our mission to provide cutting-edge cancer care close to home for patients across Colorado.
RMCC is part of The U.S. Oncology Network, a highly respected national organization collaborating to advance innovative care and deliver optimal outcomes. As Colorado’s leader in cancer treatment, we’ve been delivering world-class cancer care with compassion and expertise for more than 30 years, and we make our patients’ lives easier by offering coordinated care access in 19 locations throughout Colorado. So, if you find yourself facing new challenges in your health journey, we’ll be on your side, empowering Your Courage with Our Proven Experience.
# # #
Rocky Mountain Cancer Centers (RMCC) is an independent, physician-led practice that delivers leading-edge technology and treatment options and conducts innovative research. For more than 30 years, RMCC has pioneered community-based care to enable more cancer patients to receive high-quality treatment while staying close to the support of family and friends.
Rocky Mountain Cancer Centers treats more adult cancer than any other healthcare organization in Colorado, providing 19 locations and a network of 54 physicians specializing in cancer care throughout the state. RMCC is collectively focused on treating cancer and blood disorders with advanced technology and innovative research no matter where you live, while taking a community-based approach of integrated subspecialty oncology care. This enables patients to access leading-edge treatment while living at home and receiving the critical support of family and friends.
Patients who are treated at RMCC can participate in some of the most promising national clinical trials for a broad range of cancers. RMCC has played a role in the development of more than 100 FDA-approved cancer-fighting drugs – about one-third of cancer therapies approved by the FDA to date. At any given time, more than 150 national clinical trials are open throughout The Network.
Media Contacts
RMCC Media
RMCCmedia@usoncology.com